Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04103775 · ClinicalTrials.gov registry record · NA

Mechanisms of Cognitive Change

A NA study, sponsored by Colorado State University.

Terminated
Registry status
NA
Development phase
40
Enrollment target

NCT04103775: Clinical Trial NA study, sponsored by Colorado State University.

NCT04103775 is a NA study that was terminated before completion, run by Colorado State University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04103775, a NA study, was terminated before completion, sponsored by Colorado State University.

TERMINATED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This study will determine whether targeted cognitive training, a low-cost and low-risk commercial cognitive remediation therapy, directly impacts therapeutic targets as well as secondary outcomes in college undergraduates. The active intervention will be compared to an active control condition (computer games). Participants will also attend CSU TILT (The Institute for Teaching and Learning) Academic Workshops.

Primary Outcome

Change in MATRICS Consensus Cognitive Battery (MCCB) Verbal Learning Subscale. Demographically corrected T-scores (M = 50; SD = 10; higher better).

Interventions

  • BEHAVIORAL Active Control
  • BEHAVIORAL Cognitive Remediation

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-09-20
Est. Completion 2021-01-22
Phase NA
Colorado State University

94 total trials

Why NCT04103775 stopped before completion

NCT04103775 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Active Control is the first listed.

NCT04103775 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04103775 about?

NCT04103775 is a clinical study titled "Mechanisms of Cognitive Change". This study will determine whether targeted cognitive training, a low-cost and low-risk commercial cognitive remediation therapy, directly impacts therapeutic targets as well as secondary outcomes in college undergraduates. The active intervention will be compared to an active control condition (comp...

What is the current status of trial NCT04103775?

This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2019-09-20. Estimated completion is 2021-01-22.

What interventions are being tested in trial NCT04103775?

The interventions under investigation include: Active Control (BEHAVIORAL), Cognitive Remediation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04103775?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04103775's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04103775, the US trial registry maintained by the National Library of Medicine. NCT04103775 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.